Lidocaine Fresenius Kabi (Lidocaine Hydrochloride Monohydrate)

Lidocaine works by reversibly blocking voltage‑gated sodium channels on nerve and cardiac cells, preventing the rapid influx of sodium that is necessary for depolarisation. This stops the propagation of nerve impulses and suppresses abnormal cardiac electrical activity, producing anaesthesia and anti‑arrhythmic effects.

The dose is set by the prescribing clinician based on the intended indication, route of administration, patient weight, age, organ function and any concurrent medications. Standard dosing regimens are not provided here because they must be individualized for safety and efficacy.

Lidocaine’s pregnancy category is listed as unknown. It should only be used during pregnancy or lactation when the potential benefit justifies any potential risk to the fetus or infant, and under the guidance of a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Both lidocaine and bupivacaine are amide‑type local anesthetics, but lidocaine has a faster onset and a shorter duration of action, making it suitable for short procedures. Bupivacaine provides a longer block but carries a higher risk of cardiotoxicity at comparable plasma concentrations.

Lidocaine Fresenius Kabi should be stored at room temperature, below 25 °C, in its original packaging. Protect the vials from light, moisture and extreme temperatures. Do not freeze. Inspect the solution for particulate matter or discoloration before use.

The product is supplied as a sterile solution for injection. It can be administered epidurally, intramuscularly or intravenously by a qualified healthcare professional, using aseptic technique and appropriate dosing calculations for the chosen route.

Serious risks include seizures, severe cardiac arrhythmias such as ventricular tachycardia, profound hypotension or cardiovascular collapse, respiratory depression, and allergic reactions that may progress to anaphylaxis. Immediate medical attention is required if any of these events occur.

Lidocaine should be avoided in patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, in those with severe hepatic impairment without dose adjustment, and in individuals with certain cardiac conduction disorders where sodium‑channel blockade could be hazardous.